AnaptysBio Inc buy Guggenheim
Start price
10.03.25
/
50%
€15.30
Target price
10.03.26
-
Performance (%)
246.41%
End price
11.03.26
€53.00
Summary
This prediction ended on 11.03.26 with a price of €53.00. With a performance of 246.41% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 18.233% | 18.233% | 292.533% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten